<code id='E0C892CEDB'></code><style id='E0C892CEDB'></style>
    • <acronym id='E0C892CEDB'></acronym>
      <center id='E0C892CEDB'><center id='E0C892CEDB'><tfoot id='E0C892CEDB'></tfoot></center><abbr id='E0C892CEDB'><dir id='E0C892CEDB'><tfoot id='E0C892CEDB'></tfoot><noframes id='E0C892CEDB'>

    • <optgroup id='E0C892CEDB'><strike id='E0C892CEDB'><sup id='E0C892CEDB'></sup></strike><code id='E0C892CEDB'></code></optgroup>
        1. <b id='E0C892CEDB'><label id='E0C892CEDB'><select id='E0C892CEDB'><dt id='E0C892CEDB'><span id='E0C892CEDB'></span></dt></select></label></b><u id='E0C892CEDB'></u>
          <i id='E0C892CEDB'><strike id='E0C892CEDB'><tt id='E0C892CEDB'><pre id='E0C892CEDB'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:87414
          Portrait of Don Davis -- health policy coverage from STAT
          U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

          WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

          They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

          advertisement

          “We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Will Ozempic
          Will Ozempic

          Wegovy,theobesitydrug,wasinescapableattheObesityWeekconferenceinDallas.ElaineChenDALLAS—HereatObesit

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates